The vast majority of allograft materials utilized in spinal surgeries in Canada are supplied by large national tissue bank organizations and to a smaller extent, by provincial local tissue banks. In recent years, consolidation of tissue banks has become a growing trend as larger tissue organizations demonstrated abilities to develop more sophisticated and specialized allografts.
Major allograft tissue banks in Canada include Mount Sinai Allograft Technologies and the Regional Tissue Bank. Local supply is limited to donor materials received at Canadian Tissue Banks such as Mount Sinai Hospital and the Regional Tissue Bank to a large extent.
The majority of the allograft market is supplied domestically as it is simple for a Canadian tissue bank to source bone domestically and cut it up to provide cancellous or corticancellous chips or granules. Therefore, physicians do not feel it necessary to purchase proprietary allograft chips in the Canadian market and instead rely heavily on domestically sourced and distributed allograft. There is however a limited allograft bone graft market for spinal indications that is imported from U.S. sources, mainly from not for profit tissue banks like MTF.
Key Topics Covered:
1. Executive Summary
Canadian Orthopedic Biomaterials Market
Top Canadian Orthopedic Biomaterials Companies
2. Research Methodology
2.1 9-Step Methodology
2.2 Research Scope
3. Spinal Bone Graft Substitute Market
3.1 Market Overview
3.2 Market Analysis And Forecast
3.2.1 Spinal Allograft Market
3.2.2 Spinal Dbm Market
3.2.3 Spinal Synthetic Market
3.2.4 Growth Factor/Bmp Market
3.3 Procedure Unit Analysis (Including Autografts)